EMGT finds lower IOP delays progression


Malm?weden-The initial results of the Early Manifest Glaucoma Trial (EMGT), a National Eye Institute-sponsored study conducted in Sweden, suggest that IOP-lowering treatment significantly delays progression of open-angle glaucoma in patients with elevated and normal IOP.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.